Using eye drops to protect nerve cells in glaucoma
Part of Eyes & vision clinical trials.
This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a certain type of glaucoma (open-angle, normal-tension, pseudoexfoliation, or pigmentary dispersion).
- You have been using only one kind of glaucoma eye drop for at least 3 years.
- You have had eye check-ups for at least 3 years, with at least 6 visits that included eye pressure, visual field, and OCT scans.
- You have not had any additional glaucoma treatments besides laser trabeculoplasty or cataract surgery during that time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
This study tests tools to help you use your glaucoma eye drops correctly. If you've been using the same drops for at least two months, you may be able to join.
This trial tests two eye drops—Rhopressa (netarsudil) and timolol—at lowering eye pressure in people with open-angle glaucoma. The study uses a special camera to see if treatment helps protect the nerve cells in the back of the eye.
This study looks at how the optic nerve (the part of your eye that sends images to your brain) strains or bends in people who do not have glaucoma. It uses advanced eye imaging and home pressure checks to understand the nerve's health.
This study looks at how long-term use of glaucoma eye drops may affect the surface of the eye (the clear front layer). It aims to find out if these drops cause dry-eye or other surface problems, which can help doctors better manage treatment.
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.